Galapagos reported EUR11.89 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -1.21 -2.35 May/06
FY2025Q4 Dec/2025 11.89 -0.17 0.29 Feb/23
FY2025Q3 Sep/2025 -3.07 -0.41 -0.74 Nov/05
FY2025Q1 Jun/2025 -1.58 -0.17 0.11 Jul/23
FY2025Q1 Mar/2025 -2.35 -0.16 0.36 Apr/23




Eps Change Date
argenx SE USD 6.8 2.36 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Genmab DKK 3.69 2.77 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
GRIFOLS EUR 0.25 0.04 Dec/2025
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Merck EUR 1.88 0.44 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
UCB EUR 5.65 3.21 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025